United Kingdom· GB-APID-37336711000001105
Ceftriaxone 1g powder for solution for injection vials
A ceftriaxone product containing ceftriaxone, registered in United Kingdom by Cox Pharmaceuticals Ltd. The same ATC class is registered in 19 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ceftriaxone is registered in 19 of 19 countries.
Countries holding a registration under ATC J01DD04 (ceftriaxone), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 11 of them publish a price we can compare per daily dose
Ceftriaxone · ATC J01DD04
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ceftriaxone costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $3.23 in Finland to $33.98 in Switzerland — a ×11 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceftriaxone · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$33.98
- FR France$13.68
- ES Spain$5.69
- FI Finland$3.23
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ceftriaxone
- Manufacturer
- Cox Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01DD04
- ATC class
- Ceftriaxone
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5060480090002
- gtin5060480090040
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
233 interactions on record for ceftriaxone.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceftriaxone · interactions on record
233 records
- 7 severe
- 20 moderate
- 3 minor
- 203 info
Most severe, free to view
- Calcium gluconateA12AA03severe
- Calcium chlorideA12AA07severe
- Calcium glucoheptonateA12AA10severe
- Calcium chlorideB05XA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceftriaxone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesceftriaxoneSagent Pharmaceuticals
- FinlandCefonovaDr. Friedrich Eberth Arzneimittel GmbH
- CzechiaCEFTRIAXON APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- ItalyBIXONLANOVA FARMACEUTICI S.R.L.
- FranceCEFTRIAXONE ALMUS 1 g/3,5 mL, poudre et solvant pour solution injectable (IM)ARROW GENERIQUES
- GermanyCeftriaxon CnpCnp Pharma Gmbh
- SpainCEFTRIAXONA FRESENIUS KABI 1 g POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE INTRAMUSCULAR EFGFresenius Kabi España, S.A.U.
- BelgiumCeftriaxon Hameln 1 gHameln Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftriaxon Aptapharma, Ceftriaxon Ashcure
- Belgium · Ceftriaxon Hameln, Ceftriaxone Fresenius Kabi
- Bulgaria · Медаксон, Цефамед
- Cyprus · Ceftriaxone Sapiens, Ceftrix
- Czechia · Ceftriaxon Aptapharma, Ceftriaxon Kabi
- Germany · Ceftriaxon Cnp, Ceftriaxon Dali Pharma
- Denmark · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Estonia · ceftriaxone Kabi, Ceftriaxone Mip
- Spain · Ceftriaxona Fresenius Kabi, Ceftriaxona Ldp Torlan
- Finland · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- France · Ceftriaxone Almus, Ceftriaxone Arrow
- Greece · Bresec, Bresec(Iv)
- Croatia · Ceftriakson Aptapharma, Ceftriakson Pontus
- Hungary · Ceftriaxon Aptapharma, Ceftriaxon Kabi
- Ireland · Ceftriaxone Hameln, Ceftriaxone Jed Pharma
- Iceland · Ceftriaxon Fresenius Kabi, Ceftriaxon Navamedic
- Italy · Bixon, Caritex
- Lithuania · Ceftriaxone Ashcure, Ceftriaxone Kabi
- Luxembourg · Ceftriaxone Fresenius Kabi, Rocephine
- Latvia · Ceftriaxon Mip, Ceftriaxone Ashcure
- Malta · Ceftriaxone Ashcure, Ceftriaxone Dali Pharma
- Netherlands · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Norway · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Poland · Biotrakson, Ceftriaxon Aptapharma
- Portugal · Betasporina, Betasporina Im
- Romania · Cefort, Ceftriaxonă Aptapharma
- Sweden · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Slovenia · Ceftriakson Aptapharma, Ceftriakson Pontus
- Slovakia · Ceftriaxón Aptapharma, Ceftriaxon Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb81e020-3629-4d59-8e19-005ffe8de87d GET /v1/drugs/fb81e020-3629-4d59-8e19-005ffe8de87d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37336711000001105",
"desc": "Ceftriaxone 1g powder for solution for injection vials (Cox Pharmaceuticals Ltd)",
"form": "Powder for solution for injection",
"vpid": "41945311000001108",
"source": "dmd",
"vtm_id": "775120003",
"strength": "1 gram",
"substance": "Ceftriaxone",
"ingredient": "Ceftriaxone sodium",
"supplier_code": "36490011000001105"
}See everything about ceftriaxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.